» Articles » PMID: 26491548

Optical Coherence Tomography Angiography in Retinal Vascular Diseases and Choroidal Neovascularization

Overview
Journal J Ophthalmol
Publisher Wiley
Specialty Ophthalmology
Date 2015 Oct 23
PMID 26491548
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose. To assess the ability of optical coherence tomography-angiography (OCT-A) to show and analyze retinal vascular patterns and the choroidal neovascularization (CNV) in retinal vascular diseases. Methods. Seven eyes of seven consecutive patients with retinal vascular diseases were examined. Two healthy subjects served as controls. All eyes were scanned with the SD-OCT XR Avanti (Optovue Inc, Fremont CA, USA). Split spectrum amplitude decorrelation angiography algorithm was used to identify the blood flow within the tissue. Fluorescein angiography (FA) and indocyanine green angiography (ICGA) with Spectralis HRA + OCT (Heidelberg Engineering GmbH) were performed. Results. In healthy subjects OCT-A visualized major macular vessels and detailed capillary networks around the foveal avascular zone. Patients were affected with myopic CNV (2 eyes), age-related macular degeneration related (2), branch retinal vein occlusion (BRVO) (2), and branch retinal artery occlusion (BRAO) (1). OCT-A images provided distinct vascular patterns, distinguishing perfused and nonperfused areas in BRVO and BRAO and recognizing the presence, location, and size of CNV. Conclusions. OCT-A provides detailed images of retinal vascular plexuses and quantitative data of pathologic structures. Further studies are warranted to define the role of OCT-A in the assessment of retinovascular diseases, with respect to conventional FA and ICG-A.

Citing Articles

The Framework of Quantifying Biomarkers of OCT and OCTA Images in Retinal Diseases.

Liu X, Zhu H, Zhang H, Xia S Sensors (Basel). 2024; 24(16).

PMID: 39204923 PMC: 11359948. DOI: 10.3390/s24165227.


Exploring the synergistic pharmacological mechanism of Huoxiang Drink against irritable bowel syndrome by integrated data mining and network pharmacology.

Wang R, Lin Y, Xie H, Li H, Li M, He D Medicine (Baltimore). 2023; 102(39):e35220.

PMID: 37773835 PMC: 10545357. DOI: 10.1097/MD.0000000000035220.


Optical Coherence Tomography Angiography Findings in Malignant Hypertensive Retinopathy.

Mirshahi A, Karkhaneh R, Roohipour R, Rajabi M, Vahedian Z, Bazvand F J Ophthalmic Vis Res. 2022; 17(3):432-436.

PMID: 36160101 PMC: 9493431. DOI: 10.18502/jovr.v17i3.11583.


Choroidal Changes in Blood Flow in Patients with Intermediate AMD after Oral Dietary Supplement Based on Astaxanthin, Bromelain, Vitamin D3, Folic Acid, Lutein, and Antioxidants.

DAloisio R, Di Antonio L, Toto L, Rispoli M, Di Iorio A, Delvecchio G Medicina (Kaunas). 2022; 58(8).

PMID: 36013559 PMC: 9412262. DOI: 10.3390/medicina58081092.


Potential Prognostic Indicators for Patients With Retinal Vein Occlusion.

Yin S, Cui Y, Jiao W, Zhao B Front Med (Lausanne). 2022; 9:839082.

PMID: 35692537 PMC: 9174432. DOI: 10.3389/fmed.2022.839082.


References
1.
Laatikainen L . The fluorescein angiography revolution: a breakthrough with sustained impact. Acta Ophthalmol Scand. 2004; 82(4):381-92. DOI: 10.1111/j.1395-3907.2004.00284.x. View

2.
Imai A, Toriyama Y, Iesato Y, Hirano T, Murata T . En face swept-source optical coherence tomography detecting thinning of inner retinal layers as an indicator of capillary nonperfusion. Eur J Ophthalmol. 2014; 25(2):153-8. DOI: 10.5301/ejo.5000514. View

3.
Jia Y, Wei E, Wang X, Zhang X, Morrison J, Parikh M . Optical coherence tomography angiography of optic disc perfusion in glaucoma. Ophthalmology. 2014; 121(7):1322-32. PMC: 4082728. DOI: 10.1016/j.ophtha.2014.01.021. View

4.
Huang D, Swanson E, Lin C, Schuman J, Stinson W, Chang W . Optical coherence tomography. Science. 1991; 254(5035):1178-81. PMC: 4638169. DOI: 10.1126/science.1957169. View

5.
Snodderly D, Weinhaus R, Choi J . Neural-vascular relationships in central retina of macaque monkeys (Macaca fascicularis). J Neurosci. 1992; 12(4):1169-93. PMC: 6575794. View